BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 19406949)

  • 1. Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells.
    Rowzee AM; Ludwig DL; Wood TL
    Endocrinology; 2009 Aug; 150(8):3611-9. PubMed ID: 19406949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
    Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
    Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective response to insulin versus insulin-like growth factor-I and -II and up-regulation of insulin receptor splice variant B in the differentiated mouse mammary epithelium.
    Berlato C; Doppler W
    Endocrinology; 2009 Jun; 150(6):2924-33. PubMed ID: 19246539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor (IR) pathway hyperactivity in IGF-IR null cells and suppression of downstream growth signaling using the dual IGF-IR/IR inhibitor, BMS-754807.
    Dinchuk JE; Cao C; Huang F; Reeves KA; Wang J; Myers F; Cantor GH; Zhou X; Attar RM; Gottardis M; Carboni JM
    Endocrinology; 2010 Sep; 151(9):4123-32. PubMed ID: 20610571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines.
    Zhao H; Desai V; Wang J; Epstein DM; Miglarese M; Buck E
    Mol Cancer Ther; 2012 Feb; 11(2):503-13. PubMed ID: 22161861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action.
    Fulzele K; DiGirolamo DJ; Liu Z; Xu J; Messina JL; Clemens TL
    J Biol Chem; 2007 Aug; 282(35):25649-58. PubMed ID: 17553792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel nuclear localization and potential function of insulin-like growth factor-1 receptor/insulin receptor hybrid in corneal epithelial cells.
    Wu YC; Zhu M; Robertson DM
    PLoS One; 2012; 7(8):e42483. PubMed ID: 22879999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.
    Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ
    J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
    Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
    Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
    Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
    Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
    Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
    J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer.
    Buck E; Gokhale PC; Koujak S; Brown E; Eyzaguirre A; Tao N; Rosenfeld-Franklin M; Lerner L; Chiu MI; Wild R; Epstein D; Pachter JA; Miglarese MR
    Mol Cancer Ther; 2010 Oct; 9(10):2652-64. PubMed ID: 20924128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
    Brierley GV; Macaulay SL; Forbes BE; Wallace JC; Cosgrove LJ; Macaulay VM
    Endocrinology; 2010 Apr; 151(4):1418-27. PubMed ID: 20179263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-I/insulin hybrid receptors in human endothelial cells.
    Nitert MD; Chisalita SI; Olsson K; Bornfeldt KE; Arnqvist HJ
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):31-7. PubMed ID: 15607526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.
    Beneit N; Fernández-García CE; Martín-Ventura JL; Perdomo L; Escribano Ó; Michel JB; García-Gómez G; Fernández S; Díaz-Castroverde S; Egido J; Gómez-Hernández A; Benito M
    Cardiovasc Diabetol; 2016 Dec; 15(1):161. PubMed ID: 27905925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of neuroblastoma cell lines in insulin-like growth factor 1 receptor/Akt pathway-mediated cell proliferative responses.
    Qi L; Toyoda H; Shankar V; Sakurai N; Amano K; Kihira K; Iwasa T; Deguchi T; Hori H; Azuma E; Gabazza EC; Komada Y
    Cancer Sci; 2013 Sep; 104(9):1162-71. PubMed ID: 23710710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.
    Higashi Y; Holder K; Delafontaine P
    J Biol Chem; 2010 Nov; 285(47):36361-8. PubMed ID: 20843793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-type-specific roles of IGF-1R and EGFR in mediating Zn2+-induced ERK1/2 and PKB phosphorylation.
    Pandey NR; Vardatsikos G; Mehdi MZ; Srivastava AK
    J Biol Inorg Chem; 2010 Mar; 15(3):399-407. PubMed ID: 19946718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways.
    Dayyani F; Parikh NU; Varkaris AS; Song JH; Moorthy S; Chatterji T; Maity SN; Wolfe AR; Carboni JM; Gottardis MM; Logothetis CJ; Gallick GE
    PLoS One; 2012; 7(12):e51189. PubMed ID: 23300537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.